Related Experiment Video
Updated: May 1, 2026

05:31
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
2.7K
TexMi: development of tissue-engineered textile-reinforced mitral valve prosthesis
Ricardo Moreira1, Valentine N Gesche, Luis G Hurtado-Aguilar
11 Department of Tissue Engineering and Textile Implants, Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University , Aachen, Germany .
Tissue Engineering. Part C, Methods
|March 27, 2014
Summary
Researchers developed a novel living textile-reinforced mitral valve, the TexMi, to overcome limitations of current artificial valves. This tissue-engineered heart valve shows promise for improved patient outcomes in valvular heart disease treatment.
Area of Science:
- Biomaterials Engineering
- Cardiovascular Research
- Tissue Engineering
Background:
- Mitral valve regurgitation and aortic stenosis are prevalent valvular heart diseases.
- Current mechanical and biological prostheses have limitations including anticoagulation needs, calcification, and poor hemodynamic adaptation.
- Existing prostheses fail to replicate native valve annular-ventricular continuity, impacting durability and ventricular function.
Purpose of the Study:
- To develop a tissue-engineered heart valve specifically for the mitral position, addressing limitations of current substitutes.
- To create the TexMi valve, a living, textile-reinforced mitral valve mimicking native structure and function.
- To establish a proof-of-principle for a patient-specific, rapidly prototyped tissue-engineered mitral valve.
Main Methods:
- Development of the TexMi valve using a composite scaffold of fibrin gel and a textile tubular structure.
- Seeding the scaffold with ovine umbilical vein cells and dynamic stimulation in a custom bioreactor for 21 days.
- Utilizing a simple and reliable injection molding process with patient-specific rapid prototyped molds.
Main Results:
- Histological and immunohistological analyses confirmed significant tissue development, including aligned collagen and elastin deposition.
- The engineered tissue demonstrated no cell-mediated tissue contraction.
- Successful proof-of-concept for creating a tissue-engineered mitral valve adaptable to patient anatomy.
Conclusions:
- The TexMi valve represents a promising advancement in tissue-engineered heart valves for mitral valve replacement.
- The developed fabrication process allows for patient-specific valve creation, potentially improving hemodynamic performance and durability.
- This technology offers a potential solution to overcome the limitations of current prosthetic heart valves.

